Gosling Matthew M
SVP, General Counsel at DEPOMED INC
- Sold, on record
- $3.2M
- Dollars the filings state
- Form 4 sales
- 10
- Latest May 11, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DEPOMED INCSVP, General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DEPOMED INCUnusualDec 12 2012
Sold 65,702 shares at $5.84 ($384k)
Gosling Matthew M, Senior VP, General Counsel
Sold 100% of holdings ($384k position)0 shares leftFiling
- 2 Form 4 sale DEPOMED INCUnusualDec 2 +355 days
Sold 5,692 shares at $8.40 ($48k)
Gosling Matthew M, Senior VP, General Counsel
Sold 33.3% of holdings ($144k position)11,396 shares leftFiling
- 3 Form 4 sale DEPOMED INCUnusualMar 14 +102 days
Sold 21,875 shares at $14.74 ($322k)
Gosling Matthew M, Senior VP, General Counsel
Sold 65.7% of holdings ($490k position)11,396 shares left3.8x usual sizeFiling
- 4 Form 4 sale DEPOMED INCUnusualNov 19 +250 days
Sold 71,000 shares at $15.36 ($1.1M)
Gosling Matthew M, Senior VP, General Counsel
Sold 80.5% of holdings ($1.4M position)17,211 shares left5.2x usual sizeFiling
- 5 Form 4 sale DEPOMED INCPlan not statedDec 2 +13 days
Sold 8,819 shares at $15.85 ($140k)
Gosling Matthew M, Senior VP, General Counsel
Sold 21.3% of holdings ($655k position)32,501 shares left0.4x usual sizeFiling
- 6 Form 4 sale DEPOMED INCUnusualMay 11 +891 days
Sold 59,212 shares at $11.37 ($673k)
Gosling Matthew M, SVP, General Counsel
Sold 74.1% of holdings ($908k position)20,665 shares leftFirst sale on recordFiling
- 7 Form 4 sale DEPOMED INCUnusualMar 7 +300 days
Sold 45,519 shares at $6.58 ($300k)
Gosling Matthew M, SVP, General Counsel
Sold 100% of holdings ($300k position)0 shares leftFiling
- 8 Form 4 sale DEPOMED INCUnusualMay 11 +65 days
Sold 19,674 shares at $7.07 ($139k)
Gosling Matthew M, SVP, General Counsel
Sold 100% of holdings ($139k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 11, 2018 | DEPOMED INC | SVP, General Counsel | Form 4 sale | 19,674 | $139k | 100.0% | Unusual | SEC |
| Mar 7, 2018 | DEPOMED INC | SVP, General Counsel | Form 4 sale | 45,519 | $300k | 100.0% | Unusual | SEC |
| May 11, 2017 | DEPOMED INC | SVP, General Counsel | Form 4 sale | 59,212 | $673k | 74.1% | Unusual | SEC |
| Dec 2, 2014 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 8,819 | $140k | 21.3% | Plan not stated | SEC |
| Nov 19, 2014 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 71,000 | $1.1M | 80.5% | Unusual | SEC |
| Mar 14, 2014 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 21,875 | $322k | 65.7% | Unusual | SEC |
| Dec 2, 2013 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 5,692 | $48k | 33.3% | Unusual | SEC |
| Dec 12, 2012 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 65,702 | $384k | 100.0% | Unusual | SEC |
| Dec 6, 2012 | DEPOMED INC | Senior VP, General Counsel | Form 4 sale | 2,615 | $15k | 13.0% | Plan not stated | SEC |
| Aug 11, 2009 | DEPOMED INC | VP, General Counsel | Form 4 sale | 27,724 | $102k | 100.0% | Unusual | SEC |